ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 39 filers reported holding ESSA PHARMA INC in Q2 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,038 | +72.4% | 21,695 | +50.6% | 0.00% | – |
| Q2 2023 | $38,894 | +38.9% | 14,405 | +52.8% | 0.00% | – |
| Q1 2023 | $28,004 | +640.8% | 9,429 | +528.6% | 0.00% | – |
| Q4 2022 | $3,780 | -99.9% | 1,500 | +89.4% | 0.00% | – |
| Q1 2022 | $4,895,000 | +515.7% | 792 | +1314.3% | 0.00% | – |
| Q4 2021 | $795,000 | -78.1% | 56 | -87.6% | 0.00% | – |
| Q3 2021 | $3,624,000 | -70.6% | 453 | +5.1% | 0.00% | – |
| Q2 2021 | $12,314,000 | – | 431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |